Global Cardio Oncology Registry (G-COR): Registry Design, Primary Objectives, and Future Perspectives of a Multicenter Global Initiative

- Teske, Arco J., Moudgil, Rohit, Sverdlov, Aaron L., Cheng, Richard K., Makhoul, Silvia, Ghosh, Arjun K., Szmit, Sebastian, Zaha, Vlad, Addison, Daniel, Zhang, Lili, Herrmann, Joerg, Chong, Jun H., López-Fernández, Teresa, Agarwala, Vivek, Iakobishvili, Zaza, Guerrero, Patricia, Yang, Eric H., Leja, Monika, Akhter, Nausheen, Guha, Avirup, Okwuosa, Tochukwu M., Silva, Carolina C., Collier, Patrick, Barac, Ana, DeCara, Jeanne, Bauer, Brenton, Lenneman, Carrie E., Sadler, Diego, Brown, Sherry Ann, Deswal, Anita, Neilan, Tomas G., Ganatra, Sarju, Abdel Qadir, Husam, Menon, Venu

Baseline cardiovascular risk assessment in cancer patients scheduled to receive cardiotoxic cancer therapies: a position statement and new risk assessment tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in collaboration with the International Cardio-Oncology Society

- Lyon, Alexander R., Dent, Susan, Stanway, Susannah, Earl, Helena, Brezden-Masley, Christine, Cohen-Solal, Alain, Tocchetti, Carlo G., Moslehi, Javid J., Groarke, John D., Bergler-Klein, Jutta, Khoo, Vincent, Tan, Li Ling, Anker, Markus S., von Haehling, Stephan, Maack, Christoph, Pudil, Radek, Barac, Ana, Thavendiranathan, Paaladinesh, Ky, Bonnie, Neilan, Tomas G., Sverdlov, Aaron L.